MoneyWorks4Me

Zydus Lifesciences informs about press releases

20 Feb 2023 Evaluate

Zydus Lifesciences has informed that it enclosed two press releases, both dated February 20, 2023 titled ‘Zydus receives tentative approval from the USFDA for Gabapentin Tablets (Once-Daily), 300 mg and 600 mg’ and ‘Zydus receives tentative approval from the USFDA for Canagliflozin and Metformin Hydrochloride Tablets’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..